HANNAH GARNETT: Open Payments
NPI 1164907978 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 91 payments from 19 companies in 2025. Trend: 2023 $4,606 · 2024 $5,297 · 2025 $2,224
Food & beverage: $2,217Education: $7
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $428 |
| Novartis Pharmaceuticals Corporation | 26 | $398 |
| Regeneron Healthcare Solutions, Inc. | 7 | $225 |
| LEO Pharma Inc. | 7 | $183 |
| Amgen Inc. | 4 | $165 |
| ABBVIE INC. | 12 | $165 |
| PFIZER INC. | 1 | $98 |
| Lilly USA, LLC | 1 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $67 |
Products named: DUPIXENT, COSENTYX, OTEZLA, ADBRY, WAYRILZ, LITFULO, SKYRIZI, EBGLYSS.
Industry payments across AL — which companies pay providers there.
